Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharmaceutical #manufacturers #association

Posted On Jan 8 2018 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #noel #pharma

Posted On Nov 30 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #online #pharma

Posted On Aug 15 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #new #pharmaceutical #companies

Posted On Jul 9 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #sciele #pharma

Posted On Feb 12 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #manufacturing

Posted On Jan 30 2017 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #top #pharma #companies #2013

Posted On Dec 9 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #purdue #pharmaceutical

Posted On Nov 21 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharmaceutical #research #jobs

Posted On Nov 3 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …


Cipla, Aurobindo Pharma acquire products divested by Teva in US #pharma #online

Posted On Oct 27 2016 by

#aurobindo pharma # Cipla, Aurobindo Pharma acquire products divested by Teva in US On Thursday, the US FTC approved Teva’s purchase of Allergan’s generic drug-making unit. Photo: Reuters Hyderabad: Cipla Ltd, India s fifth largest drug maker, on Thursday announced that it has acquired a portfolio of three products from Teva Pharmaceutical Industries Ltd in the US, which are being divested by the Israel-based company as a precondition to its $40.5 billion acquisition of Allergan Plc s generic business. The spokesperson for Cipla confirmed the purchase without disclosing financial and product details. According to the US Federal Trade Commission (FTC), …